⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PHAT News
Phathom Pharmaceuticals, Inc. Common Stock
Shaya Prager Announces Opal Holdings Leasing Activity of 250,000 Square Feet Across Portfolio in 2025
prnewswire.com
SBUX
BAC
CI
MS
DRS
PHAT
Philatron Expands U.S. Manufacturing Capacity to Support the Surging Demand for High-Performance Data Center Cabling & A.I. Infrastructure
prnewswire.com
PHAT
NTC, con el respaldo de Wise Equity, completa la adquisición del negocio de oftalmología de Pharmathen USA - español USA - Deutsch USA - Français Italia - Italiano USA - English
prnewswire.com
PHAT
NTC, UNTERSTÜTZT VON WISE EQUITY, SCHLIESST DIE ÜBERNAHME DES OPHTHALMOLOGIE-GESCHÄFTS VON PHARMATHEN AB USA - Deutsch Italia - Italiano USA - Français USA - español USA - English
prnewswire.com
PHAT
Phathom Pharmaceuticals Announces First Patient Dosed in Phase 2 Study of VOQUEZNA® (vonoprazan) in Eosinophilic Esophagitis (EoE)
globenewswire.com
PHAT
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
globenewswire.com
PHAT
Phathom Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
PHAT
Phathom Pharmaceuticals Announces Publication of Data from Phase 3 pHalcon-NERD-301 Study Showing VOQUEZNA® (vonoprazan) Improved Nocturnal GERD Symptoms in Patients with Non-Erosive Reflux Disease
globenewswire.com
PHAT
Phathom Pharmaceuticals Appoints Sanjeev Narula as Chief Financial and Business Officer
globenewswire.com
PHAT